KOSPI · Healthcare · ₩166B
₩10,430+0.10%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
6/'26
3/'26 vs prev quarter
Short Volume 1.5% · as of 26.10.27
Among 98 제약 peers
Quarterly Revenue Growth
“이번 분기 수액 본업은 안정적이지만 이익은 더 지켜봐야 해요.”
In the company's words · 2026 2분기 filing